High Retention Among HIV-infected Children in Rwanda During Scale-up and Decentralization of HIV Care and Treatment Programs, 2004 to 2010

Pediatric Infectious Disease Journal

Volumn 32, Issue 8, 2013, Pages e341-e347

  Tene, Gilbert ^a   Lahuerta, Maria ^a   Teasdale, Chloe ^a   Mugisha, Veronicah ^a   Kayonde, Leonard ^a   Muhayimpundu, Ribakare ^a   Nyemazi, Jean Pierre ^a   Vandebriel, Greet ^a   Nsanzimana, Sabin ^a   Sahabo, Ruben ^a   Twyman, Peter ^a   Abrams, Elaine J ^a  

^a Columbia University ^*  (United States)

Author keywords

Antiretrovirals; HIV; Pediatric; Retention; Rwanda

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ANTIVIRAL THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; COUNSELING; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RWANDA; SURVIVAL; VERTICAL TRANSMISSION;

ADOLESCENT; ANTI-RETROVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; LOST TO FOLLOW-UP; MALE; NATIONAL HEALTH PROGRAMS; RWANDA;

EID: 84880639173     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31828c2744     Document Type: Article

References (29)

1. Rwanda Biomedical Center/Institute of HIV/AIDS Disease Prevention and Control, Annual Report on HIV Care and Treatment. Unpublished Report. 2012 Kigali, Rwanda Ministry of Health
2. Human Resources for Health Strategic Plan 2006-2010, R. Ministry of Health, Editor. 2006 Kigali, Rwanda Government of Rwanda
3. Leyenaar JK, Novosad PM, Ferrer KT, et al. Early clinical outcomes in children enrolled in human immunodeficiency virus infection care and treatment in lesotho. Pediatr Infect Dis J. 2010;29:340-345
4. Davies MA, Keiser O, Technau K, et al.International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. S Afr Med J. 2009;99:730-737
5. Kiboneka A, Wangisi J, Nabiryo C, et al. Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. AIDS. 2008;22:2493-2499
6. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298:1888-1899
7. Anaky MF, Duvignac J, Wemin L, et al. Scaling up antiretroviral therapy for HIV-infected children in Côte d’Ivoire: determinants of survival and loss to programme. Bull World Health Organ. 2010;88:490-499
8. van Dijk JH, Sutcliffe CG, Munsanje B, et al. HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy. PLoS ONE. 2011;6:e19006
9. Peacock-Villada E, Richardson BA, John-Stewart GC. Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries. Pediatrics. 2011;127:e423-e441
10. Fenner L, Brinkhof MW, Keiser O, et al.International epidemiologic Databases to Evaluate AIDS in Southern Africa. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr. 2010;54:524-532
11. Edmonds A, Yotebieng M, Lusiama J, et al. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med. 2011;8:e1001044
12. Rwanda Biomedical Center/Institute of HIV/AIDS Disease Prevention and Control, Activities Report. Kigali, Rwanda: Rwanda Ministry of Health 2011
13. TRAC Plus/Rwanda Ministry of Health, Guidelines for Antiretroviral Therapy in Rwanda. Kigali, Rwanda: Rwanda Ministry of Health 2005
14. TRAC Plus/Rwanda Ministry of Health, Guide de Prise en Charge des Personnes Infectées par le VIH au Rwanda. Kigali, Rwanda: Rwanda Ministry of Health. 2007
15. TRAC Plus/Rwanda Ministry of Health, Norms and Procedures for the National Pediatric HIV Program. Kigali, Rwanda: Rwanda Ministry of Health 2010
16. Centers for Disease Control and Prevention. Revised classification system for human immunodeficiency virus infection. MMWR. 1994;43:1-10
17. Kuczmarski RJ, Ogden CL, Guo SS, et al.2000 CDC growth charts for the United States: Methods and development. National Center for Health Statistics. Vital Health Stat. 2002;11:246
18. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Statist Assoc. 1999;94:496-509
19. Satagopan JM, Ben-Porat L, Berwick M, et al. A note on competing risks in survival data analysis. Br J Cancer. 2004;91:1229-1235
20. Ekouevi DK, Azondekon A, Dicko F, et al. 12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008. BMC Public Health. 2011;11:519
21. Kabue MM, Buck WC, Wanless SR, et al. Mortality and clinical outcomes in HIV-infected children on antiretroviral therapy in Malawi, Lesotho, and Swaziland. Pediatrics. 2012;130:e591-e599
22. Lowrance DW, Ndamage F, Kayirangwa E, et al. Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-2005. J Acquir Immune Defic Syndr. 2009;52:49-55
23. Rwanda Biomedical Center Institute of HIV/AIDS and Disease Prevention and Control (IHDPC), Rwanda UNAIDS Country Progress Report. Geneva, Switzerland: UNAIDS; 2012. Available at http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_RW_Narrative_Report[1].pdf. Accessed March 8, 2013.
24. Geng EH, Nash D, Kambugu A, et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010;7:234-244
25. Krishnan S, Wu K, Smurzynski M, et al.ALLRT/A5001 Team. Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis. HIV Clin Trials. 2011;12:190-200
26. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8:e1001056
27. Sutcliffe CG, van Dijk JH, Munsanje B, et al. Risk factors for pre-treatment mortality among HIV-infected children in rural Zambia: a cohort study. PLoS ONE. 2011;6:e29294
28. Janssen N, Ndirangu J, Newell ML, et al. Successful paediatric HIV treatment in rural primary care in Africa. Arch Dis Child. 2010;95:414-421
29. World Health Organization. Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach. 2010 Geneva, Switzerland World Health Organization